ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesR78.89

R78.89

Finding of other specified substances, not normally found in blood

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/11/2025

Code Description

ICD-10 R78.89 is a billable code used to indicate a diagnosis of finding of other specified substances, not normally found in blood.

Key Diagnostic Point:

The ICD-10 code R78.89 is used to classify findings of substances in the blood that are not typically present under normal physiological conditions. This may include various substances such as drugs, toxins, or metabolic byproducts that can indicate underlying health issues or exposure to harmful agents. The presence of these substances can be detected through laboratory tests, and their identification is crucial for diagnosing conditions such as poisoning, drug overdoses, or metabolic disorders. Clinicians must interpret these findings in the context of the patient's clinical presentation, history, and other laboratory results to determine the appropriate course of action. Accurate documentation of the clinical context, including symptoms and potential exposure sources, is essential for proper coding and treatment planning.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of substances that can be detected, requiring specific clinical context.
  • Need for comprehensive patient history to determine exposure or underlying conditions.
  • Potential overlap with other codes related to toxicology and substance abuse.
  • Variability in laboratory testing methods and interpretation.

Audit Risk Factors

  • Inadequate documentation linking findings to clinical symptoms.
  • Failure to specify the substance detected.
  • Misuse of the code for routine lab findings.
  • Inconsistent coding practices across different specialties.

Specialty Focus

Medical Specialties

Internal Medicine

Documentation Requirements

Detailed patient history, including medication use and exposure history.

Common Clinical Scenarios

Patients presenting with unexplained symptoms where toxicology screening is warranted.

Billing Considerations

Consideration of chronic conditions that may affect substance metabolism.

Emergency Medicine

Documentation Requirements

Acute care documentation, including immediate lab results and patient presentation.

Common Clinical Scenarios

Acute intoxication cases or overdose situations requiring rapid intervention.

Billing Considerations

Timely documentation is critical due to the fast-paced nature of emergency settings.

Coding Guidelines

Inclusion Criteria

Use R78.89 When
  • Follow official ICD
  • 10 coding guidelines, ensuring that the code is used only when the substance is specified and documented in the patient's medical record

Exclusion Criteria

Do NOT use R78.89 When
No specific exclusions found.

Related CPT Codes

80307CPT Code

Drug test, definitive

Clinical Scenario

Used when a definitive drug test is performed to identify specific substances.

Documentation Requirements

Documentation must include the reason for testing and the substances tested.

Specialty Considerations

In toxicology, ensure that the test results are clearly linked to the clinical findings.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of abnormal findings, including those related to substances not normally found in blood, improving the accuracy of clinical data and billing.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of abnormal findings, including those related to substances not normally found in blood, improving the accuracy of clinical data and billing.

Reimbursement & Billing Impact

billing.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

When should I use R78.89?

Use R78.89 when laboratory tests reveal the presence of substances not normally found in blood, and ensure that there is adequate documentation linking these findings to the patient's clinical presentation.